Pharmaceutical companies sponsoring patientenverenigingen for 1.7 million per year. Article posted 27 december 2011
If you want to support us you can do so through a donation anonymous or not. Any amount is welcome no matter how small. Click here if you want to help us to keep cancer-news online We are an ANBI organization and your donation is tax-deductible. Editorial is cancer-news independent of our sponsor managed. Unlike many other organizations as below to read.
december 27, 2011: source: e.g. NRC and RTL-news
A known message for us but perhaps not for everyone therefore, but equally here explained. RTL news made known last weekend that pharmaceutical companies sometimes patiëntenvereningen for 80 to 100% support financially and materially under the guise of sponsorship. As it turns out the lung cancer information centre for 98% to be paid by the pharmaceutical industry. And that goes beyond just to support in a form which is known and traceable. But it is widely known that in particular patient organisations and also organizations such as pharmaceutical companies also indirectly the NFK and KWF and bv. the Vereniging tegen de Kwakzalverij also support. In the list of RTL is also called KIKA, a fund that zihc inz. This publication from RTL niewus voigt on the news of Pink Ribbon last that came in the news because of the meager percentage of money donated that to really research wetenschappeljk was spent in their commitments despite the promises and publicity activities. See a.o. in our newsletter of november 2011 in which we also reported about Pink Ribbon.
In 2006, advertising of medicinal products by the CGR-Foundation Code, the conditions for sponsorship of patient organisations by pharmaceutical companies strengthened. Click here if you want to read which a medicinal plant must meet for advertising and sponsorship of patient organisations. The pharmaceutical industry seems to hold at first glance, but anyone who reads how bv. the NRC about this message can read between the lines here that nevertheless are doubts about the transparency and intentions of the support and sponsorship.
The NRC writes on this topic the following:
The fifteen largest pharmaceutical companies stakes last year for 1.7 million euro in patient groups. The asthma Fund gets with 257 thousand euros the most, followed by the Diabetes Association, which receives more than 178 thousand euros. RTL news reports that the total amount is about equal to 2008 and 2009.
The National MS Fund occupied with 129 thousand euro third place and the breast cancer Association Netherlands the fourth (85,500 euros). The lung cancer information centre is 96 percent funded by pharmaceutical companies, but President Ernst Lammers is not afraid that the independence this being affected. "We comply with all rules to prevent that."
Patients ' associations must stand up for the interests of sick patients, but in many cases, not that those clubs who know partly funded by the pharmaceutical industry. That is blame, say experts in RTL news. Professor Frits Rosendaal of Leiden University Medical Center
